Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: tommysdad who wrote (462)	12/9/1999 10:18:00 PM
From: Miljenko Zuanic	Respond to of 3044

By error and trial and irational.

To: tommysdad who wrote (462)	12/9/1999 11:18:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 3044

Um, by what? By chips, of course. I can make one (not really) out of chromosome 22 and then, voila, I have drugs for any disease that has genetic origin therein. Hmm, if people really believe the crp above (or very* similar one being spouted by Wild Bill among others), I can begin to understand the valuations of some of these companies. Either that, or someone has figured out that most of the bioinformatics software can be made to run under LINUX, or should I say LNUX instead? In fairness to MLNM, I never heard them come up with millennial statments like above. They do have a good number of honest chemists in house, plus the ones coming with the LKST deal. They do know this game is not easy. In the mean time, this is turning into a nice option package for many of them. PB